Scinai CEO Amir Reichman to Head Biopharma Manufacturing Discussion at HealthIL 2026
Scinai's Role in Israel's Biopharma Manufacturing Ecosystem
On January 19, 2026, Amir Reichman, the CEO of Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), will co-lead a significant roundtable discussion focusing on biopharmaceutical manufacturing in Israel during HealthIL Week. Organized by the Manufacturers Association of Israel, this event will convene industry leaders to evaluate Israel's capabilities and gaps in biopharmaceutical development and production.
The Importance of the Roundtable
The roundtable, titled **
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.